FireCyte Therapeutics
United States · $12.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- firecyte.com
- Total Funding
- $12.0M
- Last Round
- $6.5M Venture RoundJan 2022
- Rounds
- 2
About
Neuroscience-based ophthalmology company developing multi-target intravitreal anti-inflammatory proteins.
Summary
FireCyte Therapeutics is a Biotech company based in United States. It has raised $12.0M in total across 2 rounds, most recently a $6.5M Venture Round in Jan 2022. Investors include Morningside Group, AbbVie Ventures and Mass General Brigham Ventures.
Funding History
Jan 2022
Sign up to see all 2 events
Funding: Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/firecyte-therapeutics"><img src="https://indexed.vc/api/badge/company/firecyte-therapeutics" alt="FireCyte Therapeutics on Indexed.vc" width="260" height="76" /></a>